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"Everything must be made as simple as possible. But not simpler." 
- Albert Einstein 
 
The improving knowledge on dystonia etiology and associated phenomenology led to the revision of 
its definition and classification, which was published in 2013 1,2  This consensus- based classification 
aimed to facilitate diagnosis, diagnostic testing and treatment, and to assist in the development of 
research strategies.' 
The classification system includes two axes: the first axis focuses on the clinicai manifestations of 
dystonia, the second axis on etiology .1 Once a patient has been phenomenologically classified 
according to the first Axis (Table 1) a dystonia syndrome can be defined.1 To assist clinicians in 
defining a specific dystonia syndrome, Fung and colleagues listed 27 dystonia syndromes, 
supplemented with lists of potential etiologies for 16 of them.3 
The 2013 Dystonia Consensus Classification has been built thanks to the effort of world experts in 
dystonia and proposed to address some issues raised by the former classification. It has a solid 
structure, and great attention has been posed in dissecting and representing the multiple facets of 
this complex disorder. Altogether it definitely represents a step forward in the field.  
Any clinical classification, however, will only be as solid as the capacity of clinicians to interpret its 
items and translate them into the clinical evaluation in a reproducible manner. At first sight, the 
criteria of the dystonia classification seem to be clear and straightforward. However, in our 
multicenter experience, applying the criteria in clinical practice often led to discussion among 
colleagues, because the terms of the classification were interpreted in different ways. Such 
variability in interpretation carries the risk of different diagnostic and treatment strategies being 
employed, and may well hamper the search for phenotype-genotype correlations. 
To trigger discussion on the terms of classification we use a clinical example. A 10- year-old boy, 
born at 36 weeks with mild perinatal asphyxia, and with delayed motor milestones, presented at the 
age of 4 with episodes of 'jerky movements' of both arms triggered by emotion or stress. Later he 
developed continuous abnormal 'twisting' movements that gradually progressed over the first few 
years, to stabilize later on. He often sits in a twisted posture, his torso and head turned aside. Co-
occurrent problems are mental retardation, autism and asthma. On neurological examination ocular 
apraxia was noted with abnormal saccadic eye movements. He had cervical and truncal dystonia 
with myoclonus of both arms and action-induced dystonic posturing of both feet and both hands. 
For this case, two experienced clinicians independently assessed all Axis I items of the dystonia 
classification1 and defined the dystonia syndrome,3 based on a written vignette. Divergent answers 
were given with regard to age at onset ('infancy' and 'childhood'), disease course ('static' and 
'progressive') and associated features ('mental retardation' versus 'mental retardation, autism and 
asthma'). 
As a pilot project, to further explore the possible variability in the interpretation of the classification 
terms by different clinicians, 55 other written case vignettes of patients with dystonia with a 
suspected genetic cause (46% male, age 1-73 years)4 were assessed in the same way. Each 
description (including medical/family history, medications, neurological examination, and brain MRI 
report) was anonymously assessed by two of eight international movement disorders experts, who 
independently classified the phenomenological features according to the dystonia classification (Axis 
 1).1 We used written case reports deliberately, because these might give rise to less variability than 
video examinations, 5•8 as some choices regarding the clinical characterization have already been 
made by the author of the vignette. Interestingly, a 100% agreement for all Axis I items was 
observed in only 9/56 cases (16.l %) (for specification per item see Supplement 1-2). 
How the classification criteria may lead to ambiguity 
Although several factors may have contributed to non-agreement, a variable interpretation of 
clinical information among clinicians has possibly been driven by some ambiguity in the classification  
items themselves. To clarify this, we  will discuss some clinical  examples  for each Axis I item. 
Age at onset. Abnormal motor development in children presenting before the onset of frank dystonic symptoms, 
.generated divergent answers regarding 'age at onset' in several cases. Similarly, in combined syndromes, the 
presence of co-occurring symptoms preceding the onset of dystonic symptoms led to uncertainty concerning the 
real onset of the disorder. 
Lastly, different interpretations of the age at onset could be explained by dystonic jerks and dystonic posturing 
starting at different ages. 
Body distribution. A patient with myoclonus-dystonia with dystonia in the neck and myoclonus in the limbs could 
be classified as having focal dystonia or generalized dystonia, depending on whether the accent was put on the 
dystonic symptom or on the whole manifestation of the syndrome. In case of paroxysmal symptoms, when 
clinical examination is typically unrevealing, it turned out to be challenging to define the item 'body distribution', 
also considering that the descriptions by the patient or caregivers are often inaccurate and that there might be a 
considerable variability between the episodes described. 
Disease course. Two patients had progressive dystonic jerks and stable dystonic posturing, which in both cases 
gave rise to divergent answers regarding 'disease course'. Another illustrative case concerned a young patient 
with progressive dystonic symptoms and an abnormal motor development that had stabilized. This 
was interpreted by one clinician as a progressive and by the other clinician as a static course of 
the dystonia. 
 
Variability. In multifocal or generalized dystonia, the item 'variability' led to 
different interpretations. For example, dystonic movements could be action-specific in one part 
of the body but persistent elsewhere. Moreover, it can be unclear whether this item refers to 
symptoms (history) or signs (examination). While clinicians may tend to rely purely on clinical 
examination, for assessing "variability" the evaluation of history may be required: for example 
in case of diurnal fluctuations. Another example includes the phenomenon when only 
persistent dystonia is seen in the office, while the patient reports action-specific dystonia in 
particular situations. 
 
Isolated or combined. For paroxysmal dystonia, the item 'isolated or combined' could be 
difficult to classify, for the same reasons as described for the item 'body distribution’. Another 
source of confusion might be the interpretation of jerky movements. Despite the fact that every 
clinician had access to the same description of the phenomenology, it appeared that some 
clinicians made their own interpretation of co-occurring jerky movements, based on the 
complete clinical picture and pattern recognition, reflecting a common dilemma in clinical 
practice. For instance, jerky movements can be classified as dystonic jerks without any co-
occurring movement disorder by one clinician and as chorea or even myoclonus by another, 
leading to a different "isolated" or "combined" definition. 
 It should be noted that some of the above-mentioned classification items are interconnected; 
for example, if jerky movements are interpreted by one rater as myoclonus and by the other as 
dystonic jerks, the answers will not only differ for the item 'isolated or combined', but often for 
other items too, such as 'body distribution', 'age at onset' and 'disease course'. Furthermore, 
it goes without saying that if no agreement was reached on the phenomenological classification 
according to Axis I, this will result in different dystonia syndromes, as the list of syndromes is 
based on stratification of the classification items.3 
 
Can these issues be overcome? 
Our preliminary observations show how a classification system, when used to cover all 
complexities of the real world, can result in ambiguities in interpretation. The few examples 
presented here probably do not cover all the potential ambiguities that might rise in daily 
practice. However, we believe that our exploratory observations can be food for thought and 
the basis to propose some improvements.  
 
Theoretically, more stringent Axis I criteria might improve some of the factors leading to 
ambiguity. For example, co-existent jerks and dystonia in the same body region may be defined 
as dystonic movements rather than as myoclonus.9 Similarly, specific instructions might be 
added on how to apply the criteria, for instance for the item 'variability' it might be relevant to 
add whether it refers to symptoms (history) or signs (examination), and for the item ' disease 
course' a time frame might be added (e.g. in the past year). 
 
On the other hand, we might consider simplifying the current dystonia classification for those 
items for which it is difficult to formulate strict criteria, or to give a lower level of relevance to 
those items that may not be essential for assembling meaningful subgroups. Particularly 
because considering the options for all items of the dystonia classification, there are thousands 
of possible independent item combinations that could be generated and not all these 




Obviously, an appropriate clinical characterization will always heavily rely on the clinician's 
experience and intuition, given the nature of movement disorders. When we look at the 
classification of dystonia from a broader perspective, beyond possible adaptations of the 
classification items, we think that the variability in interpretation among clinicians can be 
reduced by both training programs and panel ratings. Strategies such as (web-based) training 
programs, analogous to the training developed for the Movement Disorder Society's Unified 
Parkinson ' s Disease Rating Scale (MDS-UPDRS)11 could improve the agreement among clinicians 
 worldwide. Furthermore, similar to what has been suggested in the field of epilepsy,12 regular 
team assessments by a panel of raters and consensus meetings, could reduce variability in 
interpretation, and form a valuable environment for continuous education and training. 
Evidently, disease classification systems, and the way we use them, are continuously evolving. 
For dystonia, this debate dates back to 1911 when Flatau and Sterling objected to the term 
"dystonia" coined by Oppenheim.13•14 Considering that the current classification of dystonia 
was established through a consensus process, we believe it is necessary to put the criteria to 
test, similar to what recently has been done for the clinical diagnostic criteria for Parkinson's 
disease.15 For dystonia, the preliminary observations described in this Viewpoint can serve as a 
starting point, but definitely more studies with solid methodology are needed, to fuel 
discussion, identify weak points, and propose further improvements. 
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